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Abstract 
Objective: To investigate the level of depressive symptoms among cancer patients undergoing chemotherapy and its association 
with sociodemographic data. A cross-sectional study was conducted among cancer patient in General Hospital Kuala Lumpur. 
One hundred eleven (111) cancer patients undergoing chemotherapy were evaluated, and their participation was on a voluntary 
basis. A well-constructed and validated questionnaire was used to assess the depressive symptom including their demographic 
and sociographic data. The results of the present investigation revealed that the level of depressive symptom in cancer patients 
did not affect between gender, ages and chemotherapy’s cycle as there showed no significant difference. However, the result 
showed a significant difference between marital statuses. This finding would be useful and beneficial to healthcare services 
which might improve in management and intervention on psychological of patient undergoing chemotherapy. Other factors that 
contributed to depression among cancer patient also need to be investigated.   
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1. Introduction  
Cancer is the second leading cause of death (Polikandrioti et al., 2008). The risk factors that lead to cancer 
include chemical carcinogens, age, lifestyle factors, radiation, infection and immune system. Surgery, chemotherapy, 
and radiotherapy are the most common treatment of cancer to cure or control from spreading throughout the body 
(Tim, 2012). Patient diagnosed with cancer commonly having depressive symptoms (Kim et al., 2006). About 15-
25% of cancer patients are affected by depression reports by The National Cancer Institute (2008) (Bayer, 2009). 
Chemotherapy is a type of cancer treatment that uses drugs to destroy the cancer cells. The cancer patient receiving 
chemotherapy may lead to depressive symptoms and worsening during chemotherapy (Polikandrioti et al., 2008). 
According to National Cancer Registry (2011), the symptoms of depression were included sadness, loss of interest, 
changes in eating and sleeping habits, nervousness, slow physical and mental responses, feeling guilty, unable to 
focus and frequent thoughts of death or suicide. In diagnosing depression, physical and mental state assessment, as 
well as laboratory investigations, were commonly evaluated.  
Apart from genetic factor, nutritional intakes and family history, the demographic factors were also contributed to 
depressive symptoms in cancer patients who undergone chemotherapy. The previous study had been shown that 
women have the higher prevalence of depressive symptoms than male. On the other hand, depression level decreases 
inversely with increases of age (Miaskowski, 2004). Other study conducted by Beyer (2009) claimed that young 
unmarried women have the higher risk of developing depression. This finding was parallel with Hann et al. (2002) 
who stated that high social support from family member results in reducing the depression symptoms. However, 
there were limited finding on the association between the level of depressive symptoms and demographic factors 
such as age, gender, marital status as well as chemotherapy’s cycle. Hence, these findings can provide a baseline 
information that may potentially be important for the healthcare provider in providing accurate and efficient 
management, especially in the cancer patient.  
2. Materials and methods 
2.1. Sampling  
One hundred eleven (111) respondents of the cancer patient who was undergoing chemotherapy at General 
Hospital Kuala Lumpur were evaluated. The researchers have explained the purpose of conducting the research to 
the respondents before data collection. All experiments were conducted according to the guideline proved by Ethic 
Committee of UiTM Puncak Alam (UiTM 600-FSK (PT. 5/2)), the director of Kuala Lumpur Hospital, Head of 
Department of Oncology Unit and National Medical Research (reference number 15333).  All data collection were 
kept confidentially and only been used for academic purposes. 
2.2. Selection criteria 
Some criteria must be included to form a sample population.  
Inclusion Criteria  
x 18 years of age and above  
x Cancer patient undergoing chemotherapy  
x Conscious patient 
 
Exclusion Criteria  
x Cancer patient undergoing radiotherapy 
2.3. Questionnaire 
 The researcher used the survey as the instrument for data collection. The level of the depressive symptom of 
respondents was scored using the Center for Epidemiologic Studies Depression Scale (CESD) tool. The 
questionnaire consists of three parts. Part A includes the question related to sociodemographic data such as gender, 
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age, marital status, chemotherapy's cycle, stages and type of cancer. Part B includes the question regarding on the 
level of depression symptoms whereas Part C includes the respondent's feeling to depression. All respondents have 
fulfilled the questionnaire within 15 minutes and were scored according to the scoring system as indicated below:  
 
x Score less than 15   :  not appear to be experiencing high levels of depressive symptom 
x Score 15-21     :  mild to moderate depressive symptom 
x Score more than 21 : high level of depressive symptom  
2.4. Statistical data analysis 
Statistical Package for Social Science (SPSS) software was used in this study. Data was analyzed by using 
descriptive analysis followed by Spearman’s Rank Correlation Test to identify the relationship between variables. 
P< 0.10 was considered as significant differences. 
 
3. Results  
From a total of 111 respondents in the study, there were 67 (60.4%) male patients and 44 (39.6%) female 
patients. Sixty-one (55%) of the patients involved in this study were above 50 years of age, followed by 34 (36.6%) 
of 30-49 years old and 16 (14.4%) of 18-29 years old. About marital status, 13 (11.7%) were unmarried, 92 (82.9%) 
married and 6 (5.4%) were divorced. Based on data of chemotherapy cycle during the study, 9.0% was in the first 
cycle, 16.2% was in the second cycle, 20.7% was in the third cycle, and 54.1% was in the forth cycle and above (See 
Table 1).   
 
   Table 1. Sociodemographic data   
Characteristic n % 
Gender 
               
Male 
Female  
 
7 
44 
60.4 
39.6 
Age  18-29 
30-49 
Above 50 
 
16 
34 
61 
14.4 
36.6 
55 
Marital status 
 
Single 
Married 
Divorced 
 
13 
92 
6 
11.7 
82.9 
5.4 
Chemotherapy 
cycles 
 
1st 
2nd 
3rd 
4th and above 
 
10 
18 
23 
60 
9.0 
16.2 
20.7 
54.1 
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  Table 2. Level of depressive symptoms of cancer patients undergoing chemotherapy 
Depressive symptoms  n % 
No experiencing depressive symptoms 60 54.1 
Mild to moderate depressive symptoms 
Possibility of major depressive symptoms 
24 
27 
21.8 
24.3 
 
For the level of the depressive symptom of the total sample in the study, there was 54.1% ) for the total of no 
depressive symptom which, (21.8 [n=24]) was the total of mild to depressive symptom level. The high-level 
depressive symptom associated with major depression is much higher compare to moderate depressive symptom 
level with total (24.3% [n= 27]). In regard to gender, from 111 of cancer patient undergoing chemotherapy, for 
males, (53.7% [n=36) having no depressive symptom, (22.4% [n=15]) was mild to moderate of depressive symptom 
and (23.9% [n=16]) was high level of depressive symptom associated with major depressive symptom. While 
female gender, (54.5% [n=24]) was no depressive symptom, (20.5% [n=9]) was mild to moderate of depressive 
symptom and (25% [n=11]) was a high level of the depressive symptom associated with the major depressive 
symptom.   
Regarding age category, for 18-29 years old, (62.5% [n=10) having no depressive symptom, (18.75% [n=3]) was 
mild to moderate of depressive symptom and (18.75% [n=3]) was the high level of depressive symptom associated 
with major depressive symptom. While 30 – 49 years old, (53% [n=18]) was no having depressive symptom, (29.4% 
[n=10]) was mild to moderate of depressive symptom and (17.6% [n=6]) was the high level of the depressive 
symptom associated with the major depressive symptom. For 50 years old and above, (52.5% [n=32) having no 
depressive symptom, (18% [n=11]) was mild to moderate of depressive symptom and (29.5% [n=18]) was high 
level of depressive symptom associated with major depressive symptom.  
Regarding marital status of participants, for single, (69.2% [n=9) having no depressive symptom, (7.7% [n=1]) 
was mild to moderate of depressive symptom and (23% [n=3]) was high level of depressive symptom associated 
with major depressive symptom. While for married, (55.4% [n=51]) was no having depressive symptom, (20.7% 
[n=19]) was mild to moderate of depressive symptom and (23.9% [n=22) was the high level of the depressive 
symptom associated with the major depressive symptom. For divorced, (0% [n=0) having no depressive symptom, 
(66.7% [n=4]) was mild to moderate of depressive symptom and (33.3% [n=2]) was high level of depressive 
symptom associated with major depressive symptom  (See Table 3). 
Table  3. Sociodemographic data and level of depressive symptoms 
 
Characteristics 
Level of depressive symptoms 
No depressive symptoms Mild to moderate of 
depressive symptoms 
High level of depressive 
symptom associated  with 
major depressive symptoms 
 n % n % n % 
       
Gender Male 
Female 
3 
3 
 
10 
18 
32 
18.75 
18.75 
 
62.5 
53 
52.5 
10 
6 
 
3 
10 
11 
29.4 
17.6 
 
18.75 
29.4 
18 
11 
18 
 
3 
6 
18 
18 
29.5 
 
18.75 
17.6 
29.5 
 
Age 
 
 
 
 
18-29 
30-49 
Above 50 
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Marital status 
 
Single 
Married 
Divorced 
 
9 
51 
0 
69.2 
55.4 
0 
1 
19 
4 
7.7 
20.7 
23.9 
3 
22 
2 
23 
23.9 
33.3 
Chemotherapy 
cycle 
 
1st 
2nd 
3rd 
4th and above 
 
7 
7 
12 
34 
70 
38.9 
55.2 
56.7 
0 
5 
8 
11 
0 
27.8 
34.8 
18.3 
3 
6 
3 
15 
30 
33.3 
13 
25 
 
This study was used nonparametric test Spearman Rank correlation to identify the association between variables 
which met the objective 2 and 3. The statistical analysis showed no correlation between the level of depressive 
symptom and gender, p=0.992. The statistical analysis also showed no correlation between the level of depressive 
symptom and the age of participant during the study, p=0.380. According to marital status, the statistical analysis 
showed the correlation between the level of depressive symptom and marital status, p=0.064 with the confidence 
interval of 90%. Regarding the current chemotherapy cycle during the study, the statistical analysis also showed no 
correlation between the level of depressive symptom and the current chemotherapy’s cycle during the study, 
p=0.682. (see Table 4) 
Table 4. Association between gender, age, marital status, current chemotherapy cycle and the            
levels of the depressive symptom (90% of confidence interval) 
Variables p-value  
Gender p=0.992 
Age p=0.380 
Marital status p=0.064 
Current chemotherapy cycle p=0.682 
4. Discussion 
Based on (Inaba, et al., 2005), the most of the cross study stated that woman, unmarried person, lower education 
person, low income, or occupational prestige have the higher risk for depressive disorder than man, the married, and 
higher advantaged socioeconomic status (SES) position. In this study, the number of samples according to gender 
differences also had been observed where the majority of the samples are the man than the woman, the similar 
finding with another study (Lavdaniti, 2012). The statistical result showed that 54.1% did not have depressive 
symptom, 21.6% experienced mild to the moderate depressive symptom, and 24.3% had high-level depressive 
symptom associated with major depression. There was no significant difference found between age, sex, marital 
status, and educational level in the study conducted by Rezaei, and Adib-hajbaghery (2008). 
4.1. Gender 
From the result analysis of the present study on gender differences, there is no statistically significant from 
gender differences as per the previous study conducted by Polikandrioti et al., (2008) that showed women 
experienced higher depression than man but no significant statistics. The finding of the current research is parallel 
with the research finding by Farooqi, & Ahsan, (2009), Hann, et al., (2002), Linden, W. et al., (2012), Inaba, et al., 
(2005). 
The result of Farooqi, & Ahsan, (2009)'s study also supported the result of this study. The cross-sectional study 
was carried on gender differences in anxiety and depression among Pakistani cancer patients using HADS. 100 
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patients (male = 50, female = 50) were taken as samples, and the result shows that there were no significant 
differences between gender and depression.  
The study conducted by Lavdaniti, (2012) revealed that there was no statistically significant difference in the 
relationship between depression and gender. Lavdaniti, (2012) believed that the depression level affects men and 
women equally. Linden, et al., (2012) suggested that gender differences influenced in their willingness to express 
depression and women tend to apply emotional approach coping skills. 
Newport, & Nemeroff, (1998) stated that depression was a common clinical entity with the lifetime risk of Major 
depressive disorder (MDD) had been 20% to 25% of women and 7% to 12% for men where the point of prevalence 
is 5% to 9% for women and 2% to 3% for men. The Cross-National Collaborative Group found higher lifetime and 
12-month rates of major depressive disorder among women compared to men across all ten nations, including 
Taiwan, South Korea, urban women in Seoul and women in Taiwan.  
4.2. Age 
In the term of age in this study, younger patients are less depressed than older patients. (Fann, et al., 2008) In his 
study stated that younger patients have the higher risk of depression especially the first year after diagnosis of 
having breast cancer. However, no significant difference was found between level of depression and age in this 
study which is similar to Polikandrioti et al., (2008) who mentioned that his study does not show a direct association 
between depression level and age. The result of Lavdaniti, (2012) also showed there was no statistically significant 
between depression and age. In the meta-analysis of the study conducted by (Chang-quan, et al., 2010) showed there 
was no significant difference between old age cancer patient and depression. 
However, the study by Linden, et al., (2012) mentioned that there were higher prevalence rate of depression level 
among younger age cancer patients than lower prevalence rate of depression level in older age cancer patients 
(Linden, et al., (2012) (Kim, et al., 2006). The researchers believed that higher prevalence rate of depression level 
among younger age due to more disruption in daily life while the older age already had physical function 
impairments and they had prepared cognitively and emotionally in accepting the illness (Linden, et al., 2012) 
(Polikandrioti et al., 2008). Hopwood, (2000) found that there was a slight trend for lower depression level in older 
patients, but the variable did not achieve statistical significance (p = .058). 
In the literature review of Trask, (2004), using HADS tool as a unitary scale with 11 as a threshold level, it was 
found that a significant of 70% in identifying psychiatric disorder and this varied by the age of the women. 
However, < women 50 years of age showed 90% sensitive and 40% false positive rate using 11 as a threshold level, 
but in > women 50 years of age, the sensitive was 57%, and the false positive rate was 3%. 
Study conducted by Miaskowski, (2004) showed that there was interaction between age and gender on the 
depression level using Center for Epidemiological Studies-Depression scale (CES-D) where if age increased by 1 
year for men, depression level reduced by 0.33 units; while as age increased by 1 year in women, depression raised 
by 0.16 units.  According to Ahles, & Saykin, (2002), there was speculation that older adult might be exposed to the 
chemotherapy’s side effect to cognitive function. So, the age at treatment can be a predictor of the level of 
chemotherapy-induced cognitive changes. 
4.3. Marital status 
Marital distress and depression always occur especially among women (Rehman, et al., 2008). The interesting 
finding in this research is about the marital status where in this study, there are statistically significant differences 
between depression level and marital status. It found that divorced patients faced more depression than married 
patients. This present study finding matched with the previous research conducted by Lavdaniti, (2012). The Cross-
National Collaborative Group cater across all ten nations including Taiwan and South Korea found that separated 
and divorced individuals showed higher major depression prevalence compared to the married person (Inaba, et al., 
2005). The possible explanation for this is because divorced patients did not have moral support from the family 
members than the married patients that had moral support from the family members (Lavdaniti, 2012). Similar to 
other study by Pasquini, Biondi, (2007) mentioned that  social support also played an important role alleviating 
depression among cancer patients and family counseling should be implemented to educate the family members 
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about depression among cancer patients (Pasquini, & Biondi, (2007) (Hann, et al., 2002). Hann, et al., (2002) also 
shared the same confirmed result that increasing in social support were linked with the low level of depression 
among cancer patients. Hann, et al., (2002) also stated that having larger social support significantly associated with 
low depression level for women but not significant for men. In a study conducted by (Inaba, et al., 2005) it was 
stated that unmarried and formerly-married individual exhibit higher depression level scores than the married.  
4.4. Chemotherapy cycle 
In the present study, there is no significant difference between depression and chemotherapy cycles.  This finding 
is consistent with Khudhair, (2009) who mentioned that there were no significant differences found between 
depression level and chemotherapy cycle. The study conducted by Beyer, (2009) showed there were no significant 
differences in the number of depressed patients before and after treatment, and levels of depression were not 
significantly different for either type of cancers. Pandey, et al., (2006) also mentioned there was no relationship 
between chemotherapy cycle and depression. However, research conducted by Polikandrioti et al., (2008) showed 
that those undergoing chemotherapy with no response felt more depressed than those who had responded after 
chemotherapy treatment.( Polikandrioti et al., 2008) (Pandey, et al., 2006)  
The study conducted by Jim, et al., (2011) stated that there were significant differences on the main effect of 
chemotherapy cycle and depression where the depression was found on the infusion day with the higher level of 
depression than the later infusion. (Fann, et al., 2008) also showed the same result where women who received 
chemotherapy reported more psychological distress and depression compared to those who did not receive 
chemotherapy. 
Although cancer diagnosis was a marked stressor, there were other psychological and biological stressors that 
accompany cancer and developing the depressive syndrome. Chemotherapeutic agents, surgical procedures, and 
radiotherapy were the biological stressors experienced by cancer patients that include the effect of treatment as well 
as the consequences of paraneoplastic syndromes (Newport, & Nemeroff, 1998).  
The result of Cantor, et al., (2003) study showed that 70 years and over cancer patients were treated at one 
academic tertiary cancer center, faced deteriorations in emotional and functional after chemotherapy treatment.  This 
deterioration was higher in patients who faced severe side effects from chemotherapy treatment than those who did 
not, and among tumor progression patients than those with partial or complete treatment.  
The study conducted by Pandey, et al., (2006) showed that side effect symptoms appearance among cancer 
patients receiving chemotherapy. The symptoms are like tiredness, loss of appetite, dryness of mouth, nausea, and 
sleep disturbances. For breast cancer patients undergoing chemotherapy, the chemotherapy adverse effect involved 
are of fertility, sexuality and menopause-associated health problems (e.g., osteoporosis and cardiovascular disease) 
that can lead to high distress level (Fann, et al.,  2008). Khudhair, (2009) stated that the relationship between 
depression level and the physical symptoms among cancer patients was limited. This result showed that the 
depression symptoms among cancer patients undergoing chemotherapy may arise from the disease itself.  
5. Conclusion  
 
In conclusion, there was no association between the level of the depressive symptom with age, gender and 
chemotherapy's cycle, indicating that the depression was caused by the disease itself. However, there was a 
significant difference between marital statuses on depression indicating that moral support from the family member 
can minimize the depression level among cancer patient who was undergoing chemotherapy. This finding may be 
useful for the health care provider to identify the potential depression patient. Other factors that contributed to 
depression among cancer patient also need to be investigated.    
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